3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
123
Lung Neoplasms
51
Triple Negative Breast Neoplasms
36
Breast Neoplasms
34
Small Cell Lung Carcinoma
30
Ovarian Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Neoplasm Metastasis
21
Fallopian Tube Neoplasms
20
Endometrial Neoplasms
19
Neoplasms
17
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Head and Neck Neoplasms
14
Colorectal Neoplasms
11
Carcinoma
11
Prostatic Neoplasms
9
Oropharyngeal Neoplasms
9
Esophageal Neoplasms
9
Urinary Bladder Neoplasms
8
Carcinoma, Transitional Cell
8
Pancreatic Neoplasms
7
Carcinoma, Squamous Cell
7
Lung Diseases
6
Laryngeal Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Uterine Cervical Neoplasms
5
Respiratory Tract Neoplasms
5
Mouth Neoplasms
5
Mesothelioma
5
Carcinoma, Bronchogenic
5
Interventions
Bevacizumab
3
contrast agent BR1
2
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Microbubbles
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
Biopsy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Nerve Tissue
×
Carboplatin
×
90 days
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts